PEPTIDES FOR SALE

Tir/GLP-2: What Researchers Need to Know About This Next-Generation Metabolic Peptide The frontier of metabolic peptide research keeps moving forward. After tirzepatide established the dual agonist framework, researchers began asking: what happens if we bring additional receptor systems into the equation? Tir/GLP-2 is one of the compelling answers emerging from that question — combining tirzepatide’s established dual agonist mechanism with the distinct and underexplored biology of GLP-2 signaling. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is Tir/GLP-2 as a Research Compound? Tir/GLP-2 is a next-generation multi-receptor research compound that combines elements of tirzepatide’s GLP-1/GIP dual agonism with activity at the GLP-2 receptor (GLP-2R). It represents a step beyond the dual agonist framework — not by adding glucagon agonism (as retatrutide does), but by incorporating a fundamentally different receptor system with a distinct tissue profile. GLP-2 (Glucagon-Like Peptide-2) is a lesser-known incretin hormone that is co-secreted with GLP-1 from intestinal L-cells in response to food. While GLP-1 and GIP focus primarily on pancreatic and appetite effects, GLP-2 has a very different primary target: the gastrointestinal tract — specifically the intestinal mucosa. How Tir/GLP-2 Differs from Standard Tirzepatide Standard tirzepatide engages GLP-1 and GIP receptors — a metabolic-focused combination primarily affecting the pancreas, brain, and fat tissue. Adding GLP-2 receptor activity fundamentally expands the tissue targeting: GLP-2 receptors are expressed predominantly in the intestinal mucosa, enteric nervous system, and — to a lesser extent — in bone tissue. This gives Tir/GLP-2 a broader tissue reach than tirzepatide alone. The GLP-2 component adds intestinal trophic effects — research shows GLP-2 promotes growth and maintenance of intestinal villi, increases intestinal surface area, and enhances nutrient absorption capacity. GLP-2 has demonstrated strong gut barrier-protective effects in research — increasing tight junction protein expression and reducing intestinal permeability. Some research suggests GLP-2 signaling has anti-inflammatory effects in the gut — reducing mucosal cytokine production and inflammatory cell infiltration in colitis models. What Research Shows About Its Metabolic Effects The research rationale for combining tirzepatide-like metabolic effects with GLP-2 activity is compelling from several angles: Nutrient absorption optimization: GLP-2’s trophic effects on the intestinal mucosa mean that the metabolic improvements driven by GLP-1/GIP agonism may be supported by an enhanced gut absorptive surface — allowing the metabolic system to function more efficiently overall. Gut-brain axis: GLP-2 signals through the enteric nervous system and may modulate gut-brain communication in ways that complement GLP-1’s central appetite effects. Researchers are examining whether GLP-2 adds a peripheral satiety signal layer through intestinal stretch and nutrient sensing mechanisms. Bone metabolism: GLP-2 has been documented in research to reduce bone resorption markers — an intriguing finding that connects metabolic peptide research to bone health research in a novel way. Mucosal protection during caloric restriction: In models of significant caloric restriction, the gut lining can atrophy. GLP-2’s trophic effects may counteract this, preserving gut integrity during periods of reduced caloric intake — a practically relevant finding given that GLP-1/GIP agonism often dramatically reduces food intake in research models. Why It’s Gaining Attention in Advanced Metabolic Research The research interest in Tir/GLP-2 reflects a broader trend in metabolic science: moving from single-system to multi-system interventions. The gut is now recognized as a metabolic organ in its own right — not just a passthrough for nutrients. By combining a powerful metabolic signaling compound with a gut-targeting peptide, researchers can study how metabolic improvement and gut optimization interact. For researchers studying obesity, metabolic syndrome, gut-associated metabolic disorders, or the gut-brain axis, Tir/GLP-2 opens research questions that weren’t accessible with earlier-generation compounds. It’s also an important compound for researchers trying to understand why some metabolic interventions produce stronger and more durable outcomes than others — the gut biology piece may be a key variable that prior research didn’t fully account for. Get Tir/GLP-2 for Your Advanced Metabolic Research PeptiVigor offers Tir/GLP-2 for qualified laboratory research applications. As one of the newest entries in our metabolic research catalog, it represents the current frontier of multi-receptor peptide science. Visit peptivigor.com to explore our full metabolic research compound catalog. Use code LABVIP1 at checkout for 15% off your order — and stay ahead of the research curve.

Retatrutide vs Tirzepatide: What the Latest Research Shows About Triple vs Dual Agonists The race to understand next-generation metabolic compounds has produced some genuinely exciting research in recent years. Retatrutide — a triple agonist — is now being actively compared to tirzepatide — a dual agonist — in research settings, and the data coming out of these comparisons is reshaping how scientists think about metabolic intervention targets. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. A Quick Recap: What Is Tirzepatide? Tirzepatide is a dual GLP-1/GIP agonist — a single molecule that activates both the glucagon-like peptide-1 receptor and the glucose-dependent insulinotropic polypeptide receptor simultaneously. Research has consistently shown that this dual mechanism produces stronger metabolic effects than GLP-1 agonism alone, with a growing body of data supporting its role in metabolic research. What Is Retatrutide? The Triple Agonist Explained Retatrutide takes the dual agonist concept one step further. It’s a GLP-1/GIP/glucagon triple agonist — meaning it activates all three receptors with a single molecule. Adding glucagon receptor agonism to the already-powerful dual agonist framework is the key research differentiator. The glucagon receptor piece is particularly interesting to researchers. Glucagon is typically thought of as the counter-hormone to insulin — it raises blood sugar and mobilizes energy stores. But at the doses used in research models, glucagon receptor activation in the context of GLP-1/GIP co-agonism appears to produce a different profile than glucagon alone: Glucagon receptor activation in the liver drives increased energy expenditure and fat oxidation — effects that complement the appetite and insulin sensitivity effects of GLP-1 and GIP. In research models, glucagon agonism has been associated with increased basal metabolic rate, which researchers believe contributes significantly to the enhanced weight reduction observed with retatrutide vs tirzepatide. The liver effects of glucagon — including fatty acid oxidation and ketogenesis — may also contribute to reductions in hepatic fat, making retatrutide particularly interesting for non-alcoholic fatty liver disease (NAFLD) research. What Studies Show: Triple vs. Dual Agonism Head-to-head research comparing retatrutide and tirzepatide has produced some striking findings: Greater body weight reduction: Phase 2 clinical research data shows retatrutide producing significantly greater reductions in body weight markers than tirzepatide at comparable stages of research. Enhanced fat mass reduction: Researchers using imaging techniques have noted greater reductions in both subcutaneous and visceral fat in retatrutide research arms. Liver fat: Research suggests retatrutide’s glucagon component contributes to meaningful reductions in liver fat content, an effect less pronounced with dual agonists. Metabolic rate: Studies examining energy expenditure markers suggest retatrutide increases basal metabolic activity — a thermogenic effect attributed primarily to glucagon receptor engagement. Why Researchers Are Excited About the Triple Mechanism The triple mechanism addresses metabolic regulation at three distinct but complementary levels. GLP-1 handles appetite and glucose-dependent insulin release. GIP handles insulin sensitivity and fat tissue metabolism. Glucagon handles hepatic energy mobilization and thermogenesis. Together, they create a more complete metabolic intervention signal than any two-receptor approach can achieve. For researchers modeling obesity, metabolic syndrome, or fatty liver disease, retatrutide offers a tool to study what coordinated triple-receptor engagement looks like across metabolic systems simultaneously. Explore Triple Agonist Research at PeptiVigor PeptiVigor carries Ret/GLP-3 for qualified laboratory research. Our metabolic peptide catalog includes the latest generation of multi-receptor research compounds. Visit peptivigor.com to explore our full range. Use code LABVIP1 at checkout for 15% off your order.

PEG-MGF: The Muscle Growth Factor Peptide Researchers Study for Recovery In the study of muscle repair and regeneration, researchers are always looking for compounds that can help them understand how muscle tissue responds to damage and rebuilds itself. PEG-MGF — pegylated Mechano Growth Factor — has emerged as one of the most interesting tools in this area, offering a longer-lasting research window into satellite cell biology and muscle repair mechanisms. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is PEG-MGF? To understand PEG-MGF, you need to start with MGF (Mechano Growth Factor), a splice variant of the IGF-1 (Insulin-like Growth Factor 1) gene. When muscle tissue experiences mechanical stress — like the microdamage caused by exercise — local IGF-1 gene expression shifts toward producing MGF rather than systemic IGF-1. This local splice variant appears to play a specialized role in muscle repair that differs from systemic IGF-1’s broader growth effects. The problem with native MGF in research is its extremely short half-life — estimated at just a few minutes in the bloodstream. This makes it difficult to study in vivo, because the compound degrades before researchers can observe its full range of effects. That’s where pegylation comes in. PEG-MGF is MGF that has been modified by attaching polyethylene glycol (PEG) chains to the peptide molecule. This process dramatically extends the half-life. Research estimates PEG-MGF has a half-life of days rather than minutes, making it far more practical for in vivo research protocols that need sustained compound exposure. How Pegylation Extends Half-Life Pegylation works through several mechanisms: The PEG chains increase the hydrodynamic size of the molecule, making it too large for rapid kidney filtration (renal clearance). PEG shields the peptide from proteolytic enzymes that would normally break it down quickly. The modified molecule may interact with albumin in a way that further extends circulation time. The result is a compound that stays active in the research model long enough to observe meaningful downstream effects — something impossible with native MGF. What Research Shows About Satellite Cell Activation The most critical research finding around MGF and PEG-MGF involves satellite cells — the muscle stem cells responsible for muscle repair and regeneration after damage. Research shows that MGF plays a distinct and early role in the satellite cell activation cascade: Studies demonstrate that MGF activates quiescent (dormant) satellite cells at the site of muscle damage, prompting them to begin proliferating. Research suggests MGF’s action is upstream of systemic IGF-1 — it fires first to mobilize satellite cells, while IGF-1 subsequently drives differentiation and muscle fiber formation. In muscle damage models, PEG-MGF has been shown to significantly increase satellite cell proliferation compared to controls, with researchers noting increased markers of muscle repair activity. Some studies have shown that PEG-MGF administration after induced muscle damage accelerates the recovery of muscle function and reduces fibrotic (scar tissue) markers — a finding of interest in rehabilitation and recovery research. Why Researchers Study PEG-MGF After Muscle Damage Models The specific timing of PEG-MGF’s role — activating satellite cells at the moment of injury — makes it a valuable probe for understanding the earliest stages of muscle repair. By manipulating MGF signaling in muscle damage models, researchers can ask: How important is the early satellite cell activation signal to overall recovery quality? What happens when that signal is amplified or delayed? PEG-MGF also offers a way to study muscle recovery in contexts where natural MGF production may be impaired — such as in aging models where the anabolic response to mechanical stress is blunted. This connects PEG-MGF research to broader sarcopenia and muscle aging science. Add PEG-MGF to Your Recovery Research Protocol PeptiVigor stocks PEG-MGF 2mg for laboratory research applications. Our compound is produced to high purity standards for reliable research use. Browse our muscle biology research catalog at peptivigor.com. Use code LABVIP1 at checkout for 15% off your order.

Follistatin 344: The Myostatin Inhibitor at the Edge of Muscle Research If you follow sports science or muscle biology research, you’ve probably come across the concept of myostatin — the protein that acts as a natural brake on muscle growth. And if you’ve looked into myostatin, you’ve likely encountered Follistatin 344, the compound researchers use to study what happens when that brake is released. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is Follistatin 344? Follistatin 344 is an isoform of follistatin, a naturally occurring glycoprotein produced throughout the body — including in muscle, liver, ovaries, and pituitary gland. The “344” refers to the 344-amino-acid splice variant, which is the primary circulating form of follistatin in the bloodstream and the most relevant to muscle biology research. Follistatin belongs to a family of proteins called binding proteins — its primary job is to bind to and neutralize members of the TGF-beta superfamily of signaling proteins. This family includes several important regulators of tissue growth, and the one that makes follistatin most interesting to muscle researchers is myostatin. How Follistatin Inhibits Myostatin Myostatin (also known as GDF-8, or Growth Differentiation Factor 8) is a protein produced predominantly in skeletal muscle that acts as a powerful negative regulator of muscle growth. In simple terms: myostatin tells muscle tissue to stop growing. Its evolutionary purpose appears to be preventing excessive muscle development that would be metabolically costly for the body to maintain. When myostatin binds to its receptors (ActRIIB), it activates the Smad2/3 signaling pathway, which suppresses satellite cell activation, protein synthesis, and muscle fiber development. Follistatin 344 works by binding directly to myostatin with high affinity, sequestering it and preventing it from reaching its receptor. With myostatin neutralized, the inhibitory brake on muscle development is released. What Animal Research Shows The most dramatic demonstrations of follistatin’s effects come from animal research, which has produced some of the most striking results in muscle biology: Myostatin knockout mice — animals genetically engineered without functional myostatin — develop roughly twice the muscle mass of normal mice, with dramatically reduced fat tissue. Follistatin overexpression produces similar results. Studies in mice with elevated follistatin expression show significant increases in muscle fiber size (hypertrophy) and number (hyperplasia) — suggesting follistatin affects both the size and total count of muscle fibers. Research in primates using follistatin gene delivery has shown meaningful increases in muscle volume in specific muscle groups, advancing the science from rodent models toward more translational research. Follistatin also inhibits activin A, another TGF-beta family member involved in muscle wasting and inflammation — giving it a dual role in both muscle growth promotion and muscle loss prevention research. Why Sports Science Researchers Find It Fascinating The myostatin-follistatin axis represents one of the most compelling targets in muscle wasting disease research — conditions like muscular dystrophy, sarcopenia (age-related muscle loss), and cachexia (muscle wasting from chronic disease). Research into follistatin 344 gives scientists a tool to model what myostatin inhibition looks like at the protein level, without genetic modification. Beyond disease research, sports science researchers are intensely interested in the natural limits of muscle development and what regulates the upper ceiling of muscle growth in healthy subjects. Follistatin research sits right at that frontier. Explore Follistatin 344 for Your Muscle Research PeptiVigor offers Follistatin 344 1mg for qualified laboratory research. Due to its complexity as a glycoprotein, storage and handling should follow strict research-grade protocols. Visit peptivigor.com to learn more about our muscle biology research compounds. Use code LABVIP1 for 15% off your order at checkout.

Bacteriostatic Water: Why It Matters for Peptide Research Reconstitution Behind every successful peptide research protocol is proper preparation — and that starts with the right reconstitution solution. Bacteriostatic water is a fundamental supply for any lab working with lyophilized (freeze-dried) peptides, yet it’s often overlooked or misunderstood by newer researchers. Getting this right isn’t optional — it directly affects the stability, sterility, and usability of your research compounds. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is Bacteriostatic Water? Bacteriostatic water (BW) is sterile water for injection that contains 0.9% benzyl alcohol as a preservative. The benzyl alcohol doesn’t kill bacteria outright — instead, it inhibits their growth, which is exactly what the term “bacteriostatic” means. This is distinct from a bactericidal agent that kills bacteria. The result is a reconstitution solution that maintains sterility for multiple uses over an extended period — typically up to 28 days after the vial is first punctured when stored correctly. This multi-use property is what sets bacteriostatic water apart from other sterile solutions. Why Researchers Use Bacteriostatic Water Instead of Sterile Water This is the question every researcher should be able to answer before working with peptides. Here’s the comparison: Sterile water for injection is sterile at the point of manufacture, but it contains no preservative. Once the vial is punctured, there is no protection against microbial contamination. Sterile water is intended for single-use only. If you puncture it multiple times, you risk contaminating your entire vial. Bacteriostatic water contains benzyl alcohol, which continuously inhibits microbial growth even after the vial is punctured. This allows researchers to use the same vial multiple times over several weeks without compromising sterility. Since most lyophilized peptides are reconstituted in small aliquots — and researchers typically work with a single vial of reconstituted peptide over days or weeks — bacteriostatic water is the practical and scientifically appropriate choice for most research protocols. The 0.9% Benzyl Alcohol Preservation Factor The 0.9% benzyl alcohol concentration in bacteriostatic water is carefully calibrated. At this concentration, benzyl alcohol effectively inhibits the growth of common contaminants — including bacteria, mold, and yeast — without affecting the peptide compounds being dissolved in it. Research on benzyl alcohol at this concentration shows it to be compatible with a wide range of peptide structures, with no significant effect on peptide integrity or activity in properly prepared solutions. This compatibility is why 0.9% BW has become the standard in research reconstitution. Proper Storage Considerations in Research Settings Once a peptide is reconstituted in bacteriostatic water, proper storage is critical to maintaining compound integrity: Refrigeration: Reconstituted peptides in BW should be stored at 2-8 degrees C (standard refrigerator temperature). Cold temperature slows peptide degradation and supports the preservative action of benzyl alcohol. Avoid freeze-thaw cycles: Once reconstituted, peptides in BW should not be refrozen. Freeze-thaw cycles can disrupt peptide structure and reduce activity. If long-term storage is needed, lyophilized peptides should be stored frozen and reconstituted only when needed. Protect from light: Many peptides are light-sensitive. Vials of reconstituted peptide should be stored in a dark environment or wrapped in foil when not in use. Use within 28 days: Even with bacteriostatic preservation, reconstituted peptides in BW have a finite usable window. Most research protocols recommend using reconstituted solutions within 28 days of preparation. Inspect before use: Before any research use, researchers should inspect solutions for cloudiness, particulate matter, or color changes — all of which indicate potential contamination or degradation. Don’t Overlook Your Reconstitution Supplies The quality of your research starts with the quality of your supplies — including something as seemingly simple as water. Using the right reconstitution solution protects your peptide investment and your research data. PeptiVigor stocks Bacteriostatic Water 10mL specifically for research reconstitution purposes. It’s the same standard used across laboratory settings worldwide. Pick up a supply at peptivigor.com. Use code LABVIP1 at checkout for 15% off your order.

GHRP-2: The Growth Hormone Releasing Peptide Researchers Compare to GHRP-6 In the research world, GHRP-2 and GHRP-6 are often discussed side by side. Both are growth hormone releasing peptides that stimulate GH secretion, but they differ in key ways that matter a great deal when designing a research protocol. Understanding those differences is essential for researchers choosing the right tool for their study. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is GHRP-2? GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide — a six-amino-acid chain — that stimulates GH release by activating the ghrelin receptor (GHS-R1a). This receptor, found primarily in the pituitary gland and hypothalamus, is the body’s natural target for ghrelin, the “hunger hormone” that also plays a central role in GH secretion. GHRP-2 was developed as part of a broader effort to create stable, reliable GH secretagogues for research use. Unlike GHRH analogs (like CJC-1295), GHRPs work through the ghrelin pathway — a distinct but complementary mechanism that can be used independently or stacked with GHRH compounds in research protocols. GHRP-2 vs. GHRP-6: Key Research Differences GHRP-2 and GHRP-6 are structurally similar and both activate the ghrelin receptor, but their research profiles diverge in two important ways: 1. GH Release Potency Research consistently shows that GHRP-2 produces a stronger GH release signal than GHRP-6 at comparable doses. Studies in both animal models and human research subjects show GHRP-2 generating higher peak GH levels per unit dose. For researchers specifically studying GH secretion dynamics, GHRP-2 is often the more useful tool when a robust GH signal is needed. 2. Appetite Stimulation This is where the compounds diverge most practically. GHRP-6 is well-known for producing significant appetite stimulation — a side effect that researchers observe reliably and consistently in animal models. This is because GHRP-6 has strong ghrelin-like activity that reaches appetite-regulating centers in the hypothalamus. GHRP-2, while still acting on the ghrelin receptor, produces significantly less appetite stimulation in research models. Studies show a much smaller effect on food intake compared to GHRP-6. This makes GHRP-2 the preferred choice for researchers who want to isolate GH secretion effects without the confounding variable of dramatically increased caloric intake. What Studies Show About GHRP-2 Pituitary sensitivity: Research shows GHRP-2 can restore blunted GH pulsatility in older animal models where natural GH secretion has declined — relevant to aging and somatopause research. Cortisol and prolactin: Some studies note mild elevations in cortisol and prolactin alongside GH when GHRP-2 is administered — a finding researchers track as part of understanding the full hormonal context of GH secretagogue use. Synergy with GHRH: Research consistently shows that combining a GHRP like GHRP-2 with a GHRH analog produces a synergistic GH release far greater than either alone — a finding that drives many two-compound GH research protocols. Body composition markers: Animal studies have shown changes in lean mass and fat mass under sustained GHRP-2 protocols, making it useful in body composition research. Why Researchers Choose One Over the Other The choice between GHRP-2 and GHRP-6 often comes down to what variables the researcher wants to control: If the study involves food intake, appetite behavior, or energy balance, GHRP-6’s strong appetite effects make it the more interesting tool — but those same effects become a confound in studies primarily about GH. If the study is primarily about GH secretion, IGF-1 elevation, or body composition without the appetite variable, GHRP-2 is the cleaner choice with its stronger GH signal and minimal appetite impact. Order GHRP-2 for Your Growth Hormone Research PeptiVigor offers GHRP-2 5mg for laboratory research use. Our compounds are produced to high purity standards to support reproducible research outcomes. Visit peptivigor.com to browse our full GH secretagogue lineup. Use code LABVIP1 at checkout for 15% off your order.

CJC-1295 with DAC: The Long-Acting Growth Hormone Releasing Peptide Explained When researchers need to study sustained growth hormone (GH) elevation over an extended period, CJC-1295 with DAC has become one of their most reliable tools. Its unusually long half-life sets it apart from most other growth hormone secretagogues and makes it a unique subject of study in endocrine and metabolic research. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is CJC-1295 with DAC? CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) — the hypothalamic hormone that signals the pituitary gland to produce and release growth hormone. On its own, CJC-1295 would have a relatively short effective duration, like most peptides. But the addition of DAC — Drug Affinity Complex — changes that picture dramatically. DAC is a technology that allows the peptide to bind to albumin, the most abundant protein in the bloodstream. Because albumin circulates for a long time and protects bound molecules from enzymatic breakdown, attaching DAC to CJC-1295 extends its functional half-life from minutes to approximately 6 to 8 days. This is highly unusual for a peptide compound and makes it one of the longest-acting GH secretagogues studied in research. What Research Shows About Sustained GH Elevation The extended half-life of CJC-1295 with DAC means that a single administration in a research model produces a prolonged elevation of growth hormone levels rather than a brief spike. Research has documented: Sustained GH pulse amplification: Studies show CJC-1295 with DAC increases baseline GH levels and amplifies pulsatile GH release over the course of days, not hours. IGF-1 elevation: Research consistently shows corresponding elevations in IGF-1 (insulin-like growth factor 1), the primary downstream mediator of GH’s anabolic and tissue-building effects. Fat metabolism: Studies in animal models have shown increased lipolysis (fat breakdown) under sustained GH elevation, making CJC-1295 with DAC useful in body composition research. Protein synthesis markers: Research suggests sustained GH elevation promotes nitrogen retention and protein synthesis, relevant to muscle and tissue research. How CJC-1295 with DAC Differs from CJC-1295 No DAC This distinction matters a great deal in research protocol design. CJC-1295 No DAC (also called Modified GRF 1-29 or Mod GRF) has a half-life of roughly 30 minutes. It produces a shorter, more natural GH pulse that more closely mimics the body’s own pulsatile GH release pattern. Researchers choose between the two based on what they’re trying to study: CJC-1295 No DAC is preferred for studies examining pulsatile GH dynamics, circadian GH rhythm research, or protocols requiring multiple precisely timed observations. CJC-1295 with DAC is preferred when researchers want to study the effects of sustained, elevated GH over days — for instance, in longer-term body composition or tissue repair studies where consistent GH exposure is the variable of interest. The two compounds are not interchangeable in research design — the half-life difference is too significant and changes the physiological model fundamentally. Research Applications in Endocrinology and Aging CJC-1295 with DAC has found particular interest in aging and age-related decline research. GH secretion naturally declines with age (a phenomenon called somatopause), and researchers studying this decline use compounds like CJC-1295 with DAC to model what restored GH signaling might look like over extended periods in animal models. This has implications for research into muscle loss, fat accumulation, and metabolic changes associated with aging. Order CJC-1295 with DAC for Your Research Lab PeptiVigor offers CJC-1295 5mg for qualified research applications. Each batch is produced to high purity standards appropriate for laboratory use. Explore our full GH secretagogue catalog at peptivigor.com. Use code LABVIP1 at checkout to save 15% off your order.

KPV: The Anti-Inflammatory Tripeptide Getting Attention in Gut Research Gut health research is one of the fastest-growing areas of biomedical science, and a small but powerful peptide called KPV is earning serious attention from researchers focused on inflammation and mucosal healing. If you study IBD, colitis, or gut barrier function, this tripeptide deserves a place on your radar. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is KPV? KPV is a tripeptide — meaning it’s made up of just three amino acids: Lysine (K), Proline (P), and Valine (V). It’s a C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), one of the body’s natural anti-inflammatory peptides produced from the POMC (pro-opiomelanocortin) precursor protein. What makes KPV particularly interesting from a research standpoint is that despite being only three amino acids long, it retains a significant portion of the anti-inflammatory activity of the much larger alpha-MSH molecule. This makes it an efficient and targeted research tool. Melanocortin Receptor Action KPV exerts its effects primarily through the melanocortin receptor system — specifically MC1R and MC3R, both of which are expressed in immune cells, gut epithelial cells, and macrophages. When KPV binds to these receptors, research shows it: Downregulates NF-kB signaling — one of the master switches for the body’s inflammatory response Reduces the production of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1beta Activates anti-inflammatory pathways that help modulate the immune response without fully suppressing it This selective, modulating approach is one reason researchers find KPV more interesting than broad immunosuppressive compounds for studying gut inflammation. What Research Shows About Gut Inflammation The majority of KPV research has focused on the gastrointestinal tract, where its effects on the intestinal epithelium and mucosal immune system have been particularly well documented: Colitis models: Studies in animal models of induced colitis show that KPV significantly reduces inflammatory markers, shortens the duration of gut inflammation, and improves mucosal integrity scores. Gut barrier function: Research suggests KPV helps preserve and restore tight junction proteins in intestinal cells, reducing intestinal permeability — commonly called “leaky gut” in research contexts. Epithelial healing: Studies show KPV promotes the migration and proliferation of intestinal epithelial cells, accelerating the repair of damaged mucosal surfaces. Wound Healing Research Beyond the gut, KPV has also been studied in the context of wound healing and skin inflammation. Research in dermal wound models has shown that KPV reduces inflammatory infiltration at wound sites and may accelerate the transition from the inflammatory phase to the proliferative (rebuilding) phase of healing. Some researchers are also examining KPV’s potential in oral and topical delivery systems, since its small tripeptide structure means it may be more bioavailable through mucosal surfaces than larger peptides — a practical consideration in gut research where localized delivery is often preferred. Why IBD and Colitis Researchers Are Paying Attention Inflammatory bowel diseases like Crohn’s disease and ulcerative colitis involve chronic, dysregulated gut inflammation. Current treatment research often focuses on broadly suppressing the immune system, but researchers are looking for more targeted approaches. KPV’s mechanism — modulating inflammatory pathways specifically through the melanocortin system, with apparent tropism for gut tissue — makes it a compelling candidate for more targeted gut inflammation research. Order KPV for Your Gut Research PeptiVigor carries KPV 10mg for laboratory research applications. Our KPV is produced to rigorous purity standards suitable for research use. Visit peptivigor.com to learn more and place your order. Use code LABVIP1 at checkout for 15% off.

L-Carnitine: The Amino Acid Compound Every Metabolic Researcher Should Know Not every important research compound is a peptide. L-Carnitine is a naturally occurring amino acid derivative that plays a fundamental role in cellular energy production — and it has become a staple in metabolic research, often studied alongside peptides in protocols targeting fat metabolism and exercise performance. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Is L-Carnitine? L-Carnitine is a quaternary ammonium compound synthesized in the body from the amino acids lysine and methionine. It’s found naturally in high concentrations in muscle tissue and the liver, and it plays a critical role in energy metabolism at the cellular level. The body produces L-Carnitine, but it also obtains it through diet — primarily from red meat and dairy. In research settings, L-Carnitine is studied as a purified compound to examine its specific metabolic contributions without dietary confounders. The Role of L-Carnitine in Fatty Acid Transport The core function that makes L-Carnitine so interesting to metabolic researchers is its role as a shuttle molecule for fatty acids. Long-chain fatty acids cannot cross the inner mitochondrial membrane on their own — they need a carrier. L-Carnitine is that carrier. Here’s how it works: Long-chain fatty acids are activated in the cytoplasm and linked to coenzyme A (CoA) to form acyl-CoA molecules. L-Carnitine transfers the fatty acid group across the mitochondrial membrane via the carnitine shuttle system. Inside the mitochondria, the fatty acid undergoes beta-oxidation — the process that breaks it down to generate ATP (cellular energy). Without adequate L-Carnitine, this process slows dramatically. Researchers studying cellular energy production and fat oxidation use L-Carnitine to control and investigate this shuttle mechanism. What Research Shows About Energy Metabolism and Exercise Performance L-Carnitine has been studied extensively in the context of exercise physiology and metabolic efficiency: Fat oxidation rates: Research suggests L-Carnitine increases the rate of fatty acid oxidation during conditions mimicking exercise, particularly at moderate intensity. Muscle glycogen sparing: Some studies indicate that enhanced fat burning via L-Carnitine may spare muscle glycogen — a finding relevant to endurance research. Recovery markers: Research has shown reductions in markers of exercise-induced muscle damage in models where L-Carnitine was present, suggesting a potential role in post-exercise recovery science. Insulin sensitivity: Some metabolic research has linked L-Carnitine to improved glucose uptake and insulin receptor signaling, connecting it to broader metabolic health research. Why L-Carnitine Is Studied Alongside Peptides in Metabolic Research In the peptide research world, L-Carnitine often appears in multi-compound protocols alongside GLP-1 agonists, growth hormone secretagogues, and fat-loss-adjacent peptides. The rationale is straightforward: if a peptide research protocol is examining metabolic rate, fat oxidation, or body composition changes in animal models, L-Carnitine provides a well-characterized biochemical tool to examine the fatty acid transport side of the equation simultaneously. It’s also one of the most cost-effective and well-studied compounds in the metabolic research toolkit, with decades of published data to draw from — making it a reliable foundation compound in almost any metabolic study design. Add L-Carnitine to Your Research Protocol PeptiVigor carries L-Carnitine 500mg for laboratory and research applications. It’s a clean, high-quality compound suitable for metabolic research protocols. Visit peptivigor.com to order. Use code LABVIP1 for 15% off your entire order.

Glow Peptide Stack: What Research Shows About BPC-157, GHK-Cu, and TB-500 Combined Researchers interested in skin biology, collagen synthesis, and tissue regeneration have been taking a close look at a three-peptide combination that’s gaining traction in the research community. The Glow Peptide Stack — comprising BPC-157, GHK-Cu, and TB-500 — brings together three compounds with distinct but overlapping mechanisms, creating a multi-angle research tool for studying skin and connective tissue repair. All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use. What Each Peptide Contributes Individually To understand why researchers study this combination, it helps to know what each component brings to the table on its own. BPC-157 (Body Protection Compound 157) is a 15 amino acid synthetic peptide derived from a human gastric protein. Research has documented its role in angiogenesis (new blood vessel formation), fibroblast activity, and tissue repair across multiple tissue types — including skin, tendons, and gut lining. The new blood vessel formation aspect is especially relevant to skin healing research, as adequate blood supply is essential for effective wound closure and tissue remodeling. GHK-Cu (Copper Peptide) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It’s one of the most studied peptides in skin biology. Research shows GHK-Cu: Stimulates collagen and glycosaminoglycan synthesis in skin fibroblasts Promotes wound healing and skin regeneration in multiple animal models Has demonstrated antioxidant and anti-inflammatory properties in research settings Appears to reset gene expression in aged cells toward younger expression profiles — a finding that has generated significant interest in anti-aging research TB-500 is a synthetic version of Thymosin Beta-4, a peptide that regulates actin — a protein critical for cell structure and movement. Research has shown TB-500 promotes cell migration to injury sites, modulates inflammation, and supports repair in muscle, cardiac, and connective tissue models. In skin research specifically, TB-500’s role in mobilizing keratinocytes (skin cells) toward wound sites makes it a meaningful contributor to the healing equation. Why Researchers Study Them in Combination Each peptide addresses a different phase or mechanism of skin and tissue repair: BPC-157 promotes vascularization and growth factor receptor upregulation — laying the structural groundwork for healing. TB-500 drives cell migration and early inflammatory modulation — getting the right cells to the right place quickly. GHK-Cu directs collagen synthesis and skin remodeling — shaping the quality of the repaired tissue. Research suggests that these three mechanisms form a complementary sequence covering the full arc of the repair and regeneration process. Rather than targeting a single step, the stack addresses recruitment, vascularization, and structural remodeling simultaneously. Collagen and Healing Research Angles One of the most active research angles for this combination is collagen quality and density. Studies show GHK-Cu specifically upregulates the genes responsible for collagen synthesis in fibroblasts, and research suggests that when combined with BPC-157’s angiogenic effects, the nutrient supply to newly forming collagen structures may be significantly enhanced. In wound healing models, researchers have observed that combining peptides targeting different repair phases tends to produce faster closure times and better tissue quality than single-peptide approaches. The Glow Stack’s composition reflects this multi-phase thinking. Explore the Glow Stack for Your Research PeptiVigor offers Glow Peptide (BPC-157 + GHK-Cu + TB-500) as a combined research compound ready for laboratory use. Visit peptivigor.com to view the full product details. Use promo code LABVIP1 at checkout for 15% off your order.